DOCSLIB.ORG

Copyrighted Material

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Copyrighted Material Index Note: Figures and tables are indicated by ‘f ’and‘t’respectively. AA. See Alopecia areata (AA) intradermal naevus, 164, 164f Anti-proliferative agents ABPI. See Ankle brachial pressure index (ABPI) junctional naevus, 164, 164f 5 fluorouracil, 214 Acanthosis nigricans (AN), 72–73, 73f spitz naevus, 165, 165f diclofenac, 214 Acitretin, 23 Actinic keratoses (AKs) imiquimod, 214 Acne conglobata, 92–93, 93f cryotherapy, 184 ingenol mebutate, 214 Acne excoriée, 92, 92f management, 173 Arterial ulcers Acne fulminans, 92–93, 93f and SCC, 172 compression bandaging, 87 Acne keloidalis nuchae, 91, 91f sun-damaged skin, 172, 172f simple/magnetic resonance angiography, 86 Acne Acute arthropathy X-ray signs, 17, 17f ATM. See Atypical mycobacteria (ATM) androgenic hormones, 90 Acute generalised pustular psoriasis, 14, 16f Atopic dermatitis (AD), 1, 1f , 27, 28 causing factors, 90 Acute generalized exanthematous pustulosis Atrophie blanche, 84, 84f classic rash, dorsal hand secondary to taking (AGEP), 54, 54f Atypical mycobacteria (ATM), 102 oral isotretinoin, 94–95, 94f Addison’s disease, 193 cleansers, 93 AGA. See Androgenetic alopecia (AGA) Bacillary angiomatosis, 103, 103f , 117, 117f with closed/open comedones, 89, 90f AGEP. See Acute generalized exanthematous Bacterial folliculitis, 99–100, 100f conglobata/fulminans, 92–93, 93f pustulosis (AGEP) Bacterial infections diet, 91 AKs. See Actinic keratoses (AKs) antiseptic skin, 99 dry lips, oral isotretinoin, 94, 94f Allergic contact dermatitis bacillary angiomatosis, 103, 103f , 117, 117f excoriée, 92, 92f antigens, 32–33 Cat-scratch disease, 103 fluid retention, 90 immunological response, 33, 33f common patterns, 97, 98t hormone therapies, 94 T-lymphocytes, 33 cutaneous leishmaniasis, 137–139 ‘ice-pick’ scars, 92, 92f Alopecia areata (AA) deeper infection, 101–102. See Deeper infantile, 92 contact sensitization, 146 infections with inflammatory papules and pustules, 91, exclamation mark hairs, 145, 146f impetigo, 116–117 91f mycology and skin biopsy, 146 Loiasis (Loa loa), 143 keloid scars, 92, 92f nail abnormalities, 145, 146f normal skin flora, 97 keloidalis nuchae, 91, 91f prognostic markers, 145 PVL, 97, 99, 99f laser ablation, dilated telangiectatic vessels, 96 systemic immunosuppression, 146 RMSF, 103, 104f oral antibiotics/retinoids, 94, 96 topical minoxidil, 146 secondary syphilis, 103–104, 104f Rosacea. See Rosacea topical/intralesional corticosteroids, 146 staphylococcal and streptococcal covers, 99 scars, types, 92, 92f COPYRIGHTEDAN. See Acanthosis nigricans (AN)MATERIALsubcutaneous myiasis, 141–142 seasons, 91 Androgenetic alopecia (AGA) superficial. See Superficial infections sebaceous gland, pathology and histology, 89, female androgenetic alopecia, syphilis, 117, 118f 89f 145, 145f topical and systemic antibiotics, 99 stress, 90 FUT, 145 traumatic break, skin, 97 topical treatments. See Topical treatments hair transplantation, 145 tungiasis, 141 treatment, 93, 93t Angio-oedema. See Urticaria Bandaging treatment ladder, Rosacea, 91, 92 Ankle brachial pressure index (ABPI), application, 208 vulgaris. See Acne vulgaris 29, 82 classification, 207–208 Acquired melanocytic naevi Annular erythema, 71, 72f compression, 208–210 Becker’s naevus, 165, 165f Annular (ring-shaped) lesions, granuloma medicated paste, 210, 210f Blue naevus, 164, 164f annulare, 4, 7f rubber sensitivity, 210 compound naevus, 164, 164f Annular plaques, 13, 14f sternal wound, 207 halo naevus, 165, 165f Annular urticaria, 39, 40f tubular, 210 ABC of Dermatology, Sixth Edition. Edited by Rachael Morris-Jones. © 2014 John Wiley & Sons, Ltd. Published 2014 by John Wiley & Sons, Ltd. 221 222 Index two-layer long/short stretch, 210 CAD. See Chronic actinic dermatitis (CAD) clubbing, 154, 154f type I retention, 207 Calcineurin inhibitors, 213–214 colour change, 154 type II light support, 207 Calcinosis cutis, 65, 65f in situ melanoma, 159, 159f Basalcellcarcinoma(BCC) Candida albicans, 125, 126f irritant dermatitis (eczema), 152 cryotherapy, 184 Cell-mediated immunity, 138 koilonychia, 154 Gorlin’s syndrome, 173 Central centrifugal cicatricial alopecia longitudinal/transverse splits, 153 morphoeic/sclerosing type, 174, 175f (CCCA), 147 Myxoid pseudocysts, 158, 158f nodular-type, 173, 174f Cholinergic urticaria, 40 nail loss (onychomadesis), 153 pigmented, 174, 174f Chromoblastomycosis, 140 nail plate thickening, 152 recurrent nodular, 173, 174f Chronic actinic dermatitis (CAD), 46, 46f onycholysis, 152 ‘rolled edge’, 173 Chronic paronychia, 126 periungual fibrokeratomas, 159 superficial, 174, 174f Chronic psoriatic arthropathy, 17, 17f pitting, 151 surgical scars, 175 Ciclosporin A, 23 plate infection, dermatophyte fungi, 157, 157f Benign skin tumours Compression bandaging, 208–210 psoriasis, onycholysis, 155, 155f cutaneous lesions, 161 Connective tissue disease (CTD), 62 pterygium formation, lupus, 156, 156f differential diagnosis, 161, 161f Cosmetic camouflage, 216 pustules, periungual skin, 153–154 nodules, 169–170 ‘CREST syndrome’, 64 subungual exostosis, 159, 159f pattern recognition, 161 Cryotherapy subungual hyperkeratosis, 151 pigmented, 162–165 ‘freeze–thaw’ cycle, 183 transverse ridges, 152 plaques, 170–171 liquid nitrogen, canister, 183, 184f treatment, 159–160 tumour papules, 167–169 risks and precautions, 184 viral warts, 158 vascular tumours, 165–167 skin lesions, freezing, 184 DLE. See Discoid lupus erythematosus (DLE) Benign tumour nodules CTCLs. See Cutaneous T-cell lymphomas DPN. See Dermatosis papulosa nigra (DPN) eccrine poroma, 170, 170f (CTCLs) Dracunculus medinensis (Dracunculiasis), 143 epidermoid cyst, 169, 169f CTD. See Connective tissue disease (CTD) DRESS, 53–54, 54f keloid scar, ear piercing, 170, 170f CTLA-4. See Cytotoxic T-lymphocyte-associated Dressings leiomyoma, scalp vertex, 169, 169f antigen 4 (CTLA-4) adverse effects, 207 lipoma, 169, 169f Curettage surgery, 185–186 alginate, 202–203 Benign tumour papules Cutaneous B-cell lymphoma, 78, 78f alginogels, 206 apocrine hidrocystomas, 168, 168f Cutaneous leishmaniasis, 137–139, 138f antimicrobial agents, 203–204, 204f milia, 168, 169f Cutaneous T-cell lymphomas (CTCLs), 181–182, capillary action, 206 sebaceous gland hyperplasia, 168, 169f 182f categorization, 200 syringomas, 168, 168f Cytotoxic T-lymphocyte-associated antigen 4 cavity, 204, 205f trichoepitheliomas, 168, 168f (CTLA-4), 220 description, 200 Benign tumour plaques film, 201, 201f epidermal naevus, 171, 171f Darier’s disease, 153, 153f honey, 204–205, 205f ILVEN, 171 DDTUs. See Dermatology day treatment units hydrocolloid, 201, 202f naevus sebaceous, 170, 170f (DDTUs) hydrofibres, 201–202, 203f Biological therapies Dermabrasion and chemical peels, 195 hydrogel, 201, 202f Ⓡ adalimumab (Humira ),24 Dermatitis artefacta, 88, 88f interactive, 200 eczema, 220 Dermatitis herpetiformis (DH) larvae therapy, 204, 205f Ⓡ etanercept (Enbrel ),24 gastrointestinal system and liver, skin MMPs, 206 Ⓡ infliximab (Remicade ),24 changes, 75, 75f non-or low adherent, 200–201, 200f metastatic melanoma, 219–220 gluten-free diet, 59–60 odour-controlling, 204 NICE guidelines (UK), 24 investigation, immunobullous disease. See passive, 200 proteins/antibodies, 23 Immunobullous disorders patient-focused issues, 198, 200 rituximab, 220 on knees, 59, 59f PHMB, 206 T-cell mediated disease and cytokines, linear IgA, 60, 60f polyurethane foam, 203, 203f 23–24 Dermatology day treatment units (DDTUs), 19 super-absorbent, 206 treatment, psoriasis, 219 Dermatomyositis TNP, 206 Ⓡ ustekinumab (Stelara ),24–25 hands, 68, 69f Drug rashes Blashko’s lines, 80, 80f rash on ‘V’ of neck, 68, 68f AGEP, 54, 54f Blastomycosis, 141 treatment, high dose systemic alteration, normal skin function. See Normal Blepharitis, 95, 95f corticosteroids, 69 skin alteration, drug rashes Blisters, 55–56, 55f Dermatosis papulosa nigra (DPN), diagnosis, 48 Bowen’s disease, 173, 184 162, 162f DRESS. See Drug reaction with eosinophilia and Bullous lichen planus, 66, 66f DH. See Dermatitis herpetiformis (DH) systemic symptoms (DRESS) Bullous pemphigoid Diabetic/neuropathic ulcers, 87, 87f drug-induced exanthems, 51, 51f bullae, 4, 4f , 8, 9f Discoid lesions, discoid eczema, 4, 5f drug-induced lupus, 51–52, 51f histopathology, 60, 60f Discoid lupus erythematosus (DLE), 68, 68f drug-induced vasculitis, 52, 52f immunofluorescence, 60, 61f Diseases, nails erythema nodosum, 52 mouth erosions, 57, 58f acute illness, 158 examination, 48 urticated plaques, pre-bullous pemphigoid, 57, bacterial infection, periungual tissues, 157, fixed drug eruption, 52, 53f 57f 157f history, 48, 50t vesicles, 8, 9f Beau’s line, 153 immune-mediated and Bullous vasculitis with necrosis, 63, 63f chronic illness, 158, 158f non-immune-mediated, 49 Index 223 lichenoid drug eruptions, 52, 52f lichen simplex, 28, 28f superficial dermatophyte and yeast, 116, pre-existing dermatoses, 50–51 Paget’s disease, 29, 30f 122 SJS and TEN, 52–53, 53f , 53t Pityriasis alba, 27 systemic antifungal drugs, 127 skin biopsy, 48–49 plantar dermatitis, 27, 28f Tinea capitis (scalp ringworm), 122, 122f skin reactions, 49 pompholyx, 28, 29f Tinea incognito, 123, 123f urticaria/angio-oedema, 51, 51f RAST, 29 trunk, 124–125 Drug reaction with eosinophilia and systemic skin and nasal swabs, 29 yeast infections, 126–127 symptoms (DRESS), 53–54, 54f varicose, 28, 29f zoophilic (animal) fungi, 122 Drug-induced exanthems, 51, 51f venous (stasis), 28, 29 Drug-induced lupus, 51–52, 51f Eosinophilic folliculitis (EF), 116, 116f Gastrointestinal system and liver disorders Drug-induced
Load more

Recommended publications
  • Pdf/Bus Etat Des Lieux.Pdf Dermato-Allergol Bruxelles
    1. w Volume 11, Number 2 April 2020 ISSN: 2081-9390 p. 113 - 223 DOI: 10.7241/ourd Issue online since Thursday April 02, 2020 Our Dermatology Online www.odermatol.com - Soraya Aouali, Imane Alouani, Hanane Ragragui, Nada Zizi, Siham Dikhaye A case of epithelioid angiosarcoma in a young man with chronic lymphedema - Iyda El Faqyr, Maria Dref, Sara Zahid, Jamila Oualla, Nabil Mansouri, Hanane Rais, Ouafa Hocar, Said Amal Syringocystadenoma papilliferum presented as an ulcerated nodule of the vulva in a patient with Neurofibromatosis type 1 - FMonisha Devi Selvakumari, Bittanakurike Narasappa Raghavendra, Anjan Kumar Patra A case of infantile Sweet’s syndrome - Anissa Zaouak, Leila Bouhajja, Houda Hammami, Samy Fenniche Penile annular lichen planus 2 / 2020 e-ISSN: 2081-9390 Editorial Pages DOI: 10.7241/ourd Quarterly published since 01/06/2010 years Our Dermatol Online www.odermatol.com Editor in Chief: Publisher: Piotr Brzeziński, MD Ph.D Our Dermatology Online Address: Address: ul. Braille’a 50B, 76200 Słupsk, Poland ul. Braille’a 50B, 76200 Słupsk, Poland tel. 48 692121516, fax. 48 598151829 tel. 48 692121516, fax. 48 598151829 e-mail: [email protected] e-mail: [email protected] Associate Editor: Ass. Prof. Viktoryia Kazlouskaya (USA) Indexed in: Universal Impact Factor for year 2012 is = 0.7319 system of opinion of scientific periodicals INDEX COPERNICUS (8,69) (Academic Search) EBSCO (Academic Search Premier) EBSCO MNiSW (kbn)-Ministerstwo Nauki i Szkolnictwa Wyższego (7.00) DOAJ (Directory of Open Acces Journals) Geneva Foundation
    [Show full text]
  • Urticaria - Primary Care Treatment Pathway
    DORSET MEDICINES ADVISORY GROUP Urticaria - Primary Care Treatment Pathway Urticaria – also known as hives or nettle rash – is a raised, itchy rash that can occur on just one part of the body or be spread across large areas. The weals of urticaria last less than 24 hours although patients may develop new weals on a daily basis. If urticaria clears completely within six weeks, it is known as acute urticaria. Urticaria occurring for more than six weeks is referred to as chronic urticaria. Most cases of chronic disease occur without an obvious trigger (chronic spontaneous urticaria). Some urticaria has a physical trigger such as pressure (symptomatic dermographism or delayed pressure urticaria), cold or exercise (cholinergic urticaria), or may be drug induced (e.g. by NSAIDS, ACE inhibitors and opioids). All forms of urticaria can be treated with antihistamine although physical urticaria is less likely to respond to treatment than spontaneous urticaria. Most cases of urticaria settle spontaneously within two years but the condition can last for decades in some patients. Referral criteria Refer routinely to dermatology if patients are not responding to standard treatment (see primary care treatment below, up to step 4), they can then be considered for immunomodulation treatment such as ciclosporin (can be very useful for patients thought to have an autoimmune basis for their urticaria), methotrexate or omalizumab. The diagnosis of urticaria is primarily clinical therefore do not routinely refer for allergy testing. The British Association of Dermatologists (BAD) has produced a patient information leaflet which covers this in detail for patients. PRIOR TO SPECIALIST REFERRAL -conduct a full blood count (FBC), erythrocyte sedimentation rate (ESR), thyroid function tests (TFTs), liver function tests (LFTs), and Helicobacter pylori screening (if gastrointestinal symptoms are present).
    [Show full text]
  • Etiology, Classification, and Treatment of Urticaria
    CONTINUING MEDICAL EDUCATION Etiology, Classification, and Treatment of Urticaria Kjetil Kristoffer Guldbakke, MD; Amor Khachemoune, MD, CWS GOAL To understand urticaria to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Discuss the clinical classification of urticaria. 2. Recognize how to diagnose urticaria. 3. Identify treatment options. CME Test on page 50. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. December 2006. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 CreditTM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Drs. Guldbakke and Khachemoune report no conflict of interest. The authors discuss off-label use of colchi- cine, cyclophosphamide, cyclosporine, dapsone, intravenous immunoglobulin, methotrexate, montelukast sodium, nifedipine, plasmapheresis, rofecoxib, sulfasalazine, tacrolimus, thyroxine, and zafirlukast. Dr. Fisher reports no conflict of interest. Urticaria is among the most common skin dis- autoimmune mechanisms are now recognized as a eases. It can be acute, chronic, mediated by a cause of chronic urticaria. A search of the PubMed physical stimulus, or related to contact with an database (US National Library of Medicine) for urticant.
    [Show full text]
  • 10 Chronic Urticaria As an Autoimmune Disease
    10 Chronic Urticaria as an Autoimmune Disease Michihiro Hide, Malcolm W. Greaves Introduction Urticaria is conventionally classified as acute, intermittent and chronic (Grea- ves 2000a). Acute urticaria which frequently involves an IgE-mediated im- munological mechanism, is common, its causes often recognised by the patient, and will not be considered further. Intermittent urticaria – frequent bouts of unexplained urticaria at intervals of weeks or months – will be dis- cussed here on the same basis as ‘ordinary’ chronic urticaria. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks. The etiology of chronic urticaria is usually obscure. The different clinical varieties of chronic urticaria will be briefly considered here, and attention will be devoted to a newly emerged entity – autoimmune chronic urticaria, since establishing this diagnosis has conceptual, prognostic and the- rapeutic implications. Contact urticaria and angioedema without urticaria will not be dealt with in this account. Classification of Chronic Urticaria The clinical subtypes of chronic urticaria are illustrated in the pie-chart of Fig. 1. The frequency of these subtypes is based upon the authors’ experience at the St John’s Institute of Dermatology in UK. Whilst there may well be mi- nor differences, it is likely that the frequency distribution of these subtypes will be essentially similar in most centres in Europe and North America (Grea- ves 1995, 2000b). However, our experience suggests that the incidence of angioedema, especially that complicated by ordinary chronic urticaria is sub- stantially lower in Japan and south Asian countries (unpublished observation). 310 Michihiro Hide and Malcolm W.
    [Show full text]
  • ALLCHRONIC URTICARIA About ANGIOEDEMA
    ALLCHRONIC URTICARIA about& ANGIOEDEMA WHAT IS CHRONIC URTICARIA? may be a result of an immune system disorder. In very rare cases, The term chronic urticaria (CU) is another term for “chronic CU/angioedema can be identified as a reaction to a medication, hives.” Hives are an inflammation of the skin that results from cells food, insect or infection. Even when the cause cannot be identified, in your body releasing histamine and other allergic chemicals into there are common stimuli that may worsen or exacerbate the condi- the bloodstream. They appear as clusters of raised, red or white tion such as: welts that tend to be very itchy. Chronic hives are defined as hives • allergies (food, environmental) • medications that last more than six weeks, or may briefly go away, but often • temperatures (hot and cold) • illnesses recur frequently. About 40% of people with chronic urticaria often • pressure • sun exposure have another condition known as angioedema. There are several subtypes of CU, including cold urticaria, pressure urticaria, and HOW IS CU/ANGIOEDEMA DIAGNOSED? cholinergic urticaria. CU occurs in about 1% of the US population. The diagnosis of CU is based mostly on history of symptoms and physical exam that is done by either your pediatrician or an WHAT ARE THE SYMPTOMS OF CU? allergist. Although there are not specific laboratory tests that can be done to diagnose this condition, there are blood tests and allergy CU presents as hives - small or large patches that may be round, tests that can be done to identify triggers or rule out other condi- irregular shaped, rings, or may change shape throughout the day.
    [Show full text]
  • Urticaria, Angio-Oedema and Anaphylaxis
    CME Dermatology Urticaria, angio-oedema and anaphylaxis The simplest working classification is to separate urticarias into four categories (Table 2): Urticarial lesions (ie areas of superficial Clive EH Grattan MA MD FRCP, Consultant ordinary Dermatologist, Norfolk and Norwich swelling) are also seen in skin diseases physical University Hospital, Norwich other than urticaria (eg some drug reac- tions, bullous pemphigoid). In these vasculitic urticaria (urticarial Clin Med JRCPL 2002;2:20–23 conditions, the lesions do not show the vasculitis) rapid fluctuation which characterises contact urticaria. urticaria. They will not be considered Angio-oedema may be a feature of Urticaria, angio-oedema and anaphy- further in this article. most patterns of urticaria and, for the laxis are distinct clinical entities caused Angio-oedema implies deeper vascular most part, can be considered together by transient plasma leakage from small leakage producing swellings predomi- with urticaria. However, it is worth con- blood vessels. When the affected vessels nantly affecting the subcutis. They tend sidering angio-oedema separately when are superficial the result is a raised, itchy to be large, pale and painful rather than it occurs without weals (Table 3) because swelling of the skin known as a weal. red and itchy, and last longer than weals. it may then be a presentation of Involvement of deeper vessels produces Angio-oedema is a cause of distressing C1esterase inhibitor (C1 inh) deficiency tender subcutaneous and submucosal oropharyngeal swellings but may occur or a drug reaction. swellings known as angio-oedema. anywhere on the integument including Generalised plasma exudation leading to the genitalia. shock is a feature of anaphylaxis but also Ordinary urticaria Anaphylaxis is defined by a life-threat- occurs in anaphylactoid reactions and ening fall in blood pressure, difficulty Ordinary urticaria is a useful collective the capillary leak syndrome.
    [Show full text]
  • Urticaria and Angioedema
    URTICARIA AND ANGIOEDEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about urticaria and angioedema. It tells you what they are, what causes them, what you can do about them, and where you can find out more about them. What is urticaria and angioedema? Urticaria is common, and affects about 20% of people at some point in their lives. It is also known as hives or nettle rash. The short-lived swellings of urticaria are known as weals (see below) and typically any individual spot will clear within 24 hours although the overall rash may last for longer. Angioedema is a form of urticaria in which there is deeper swelling in the skin, and the swelling may take longer than 24 hours to clear. An affected individual may have urticaria alone, angioedema alone, or both together. Both are caused by the release of histamine from cells in the skin called mast cells. When angioedema occurs in association with urticaria, the two conditions can be considered part of the same process. When angioedema occurs on its own, different causes need to be considered. There are different types of urticaria of which the most common form is called ‘ordinary or idiopathic urticaria’. In this type no cause is usually identified and often patients have hives and angioedema occurring together. Ordinary urticaria with or without angioedema is usually divided into ‘acute’ and ‘chronic’ forms. In ‘acute’ urticaria/angioedema, the episode lasts from a few days up to six weeks. Chronic urticaria, by definition, lasts for more than six weeks.
    [Show full text]
  • Genital Psoriasis: a Systematic Literature Review on This Hidden Skin Disease
    Acta Derm Venereol 2011 ; 91 ; 5-11 REVIEW ARTICLE Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease Kim A. P. MEEUWIS'-^ Joanne A. DE HULLU^ Leon F. A. G. MASSUGER^ Peter C. M. VAN DE KERKHOF' and Michelle M. VAN ROSSUM' Departments of 'Dermatology and 'Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands It is well known that the genital skin may be affected by of inverse psoriasis (synonym: flexural or intertriginous psoriasis. However, little is known about the prevalence psoriasis) (2, 4, 5). and clinical appearance of genital psoriasis, and genital The external genital skin is generally classified as skin is often neglected in the treatment of psoriatic pa- flexural skin, although it forms a unique area compri- tients. We performed an extensive systematic literature sing different structures and types of epithelium. The search for evidence-based data on genital psoriasis with epithelium covering the different structures of the vulva respect to epidemiology, aetiology, clinical and histopat- changes from stratified, keratinised squamous cell epit- hological presentation, diagnosis and treatment. Three helium on the outer parts to mucosa on the innermost bibliographical databases (PubMed, EMBASE and the regions (5, 6). Similarly, the male genital epithelium Cochrane Library) were used as data sources. Fifty-nine has a different pattern of keratinisation throughout the articles on genital psoriasis were included. The results genital area. The prepuce forms the anatomical cover- show that psoriasis frequently affects the genital skin, ing of the glans penis and is the junction between the but that evidence-based data with respect to the efficacy mucosal surface of the glans and coronal sulcus and the and safety of treatments for genital psoriasis are extre- keratinised squamous cell epithelium of the remaining mely limited.
    [Show full text]
  • Aafp Fmx 2020
    Challenging Pediatric Rashes Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery University of Texas Health, San Antonio 1 ACTIVITY DISCLAIMER The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note that medical information is constantly changing; the information contained in this activity was accurate at the time of publication. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed. Rather, it is intended to present an approach, view, statement, or opinion of the faculty, which may be helpful to others who face similar situations. The AAFP disclaims any and all liability for injury or other damages resulting to any individual using this material and for all claims that might arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by a physician or any other person. Physicians may care to check specific details such as drug doses and contraindications, etc., in standard sources prior to clinical application. This material 2 might contain recommendations/guidelines developed by other organizations. Please note that although these guidelines might be included, this does not necessarily imply the endorsement by the AAFP. 2 1 Disclosure Statement It is the policy of the AAFP that all individuals in a position to control content disclose any relationships with commercial interests upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflicts of interest. If conflicts are identified, they are resolved prior to confirmation of participation.
    [Show full text]
  • Chronic Urticaria It’S More Than Just Antihistamines! Randy D
    CE/CME Chronic Urticaria It’s More Than Just Antihistamines! Randy D. Danielsen, PhD, PA, DFAAPA, PA-C Emeritus, Gabriel Ortiz, MPAS, PA-C, DFAAPA, Susan Symington, MPAS, PA-C, DFAAPA The discomfort caused by an urticarial rash, along with its unpredictable course, can interfere with a patient’s sleep and work/school. Adding to the frustration of patients and providers alike, an underlying cause is seldom identified. But a stepwise treatment approach can bring relief to all. Randy D. Danielsen is Professor and Dean CE/CME INFORMATION rticaria, often referred to as hives, is a of the Arizona School Earn credit by reading this article and common cutaneous disorder with a life- 1 of Health Sciences, successfully completing the posttest time incidence between 15% and 25%. and Director of the U Center for the Future at www.mdedge.com/clinicianreviews/ Urticaria is characterized by recurring pruritic of the Health ce/cme/latest. Successful completion wheals that arise due to allergic and nonallergic Professions at A.T. is defined as a cumulative score of at reactions to internal and external agents. The Still University in least 70% correct. Mesa, Arizona. name urticaria comes from the Latin word for Gabriel Ortiz This program has been reviewed and “nettle,” urtica, derived from the Latin word uro, practices at Breathe is approved for a maximum of 1.0 hour meaning “to burn.”2 America El Paso in of American Academy of Physician Urticaria can be debilitating for patients, who Texas and is a former Assistants (AAPA) Category 1 CME AAPA liaison to the may complain of a burning sensation.
    [Show full text]
  • Indian Journal of Dermatology, Venereology & Leprology
    Indian Journal of Dermatology, Venereology & Leprology Journal indexed with SCI-E, PubMed, and EMBASE | | VVolo l 7744 IIssues s u e 2 MMar-Apra r- A p r 220080 0 8 C O N T E N T S EDITORIAL Management of autoimmune urticaria Arun C. Inamadar, Aparna Palit .................................................................................................................................. 89 VIEW POINT Cosmetic dermatology versus cosmetology: A misnomer in need of urgent correction Shyam B. Verma, Zoe D. Draelos ................................................................................................................................ 92 REVIEW ARTICLE Psoriasiform dermatoses Virendra N. Sehgal, Sunil Dogra, Govind Srivastava, Ashok K. Aggarwal ............................................................. 94 ORIGINAL ARTICLES A study of allergen-specific IgE antibodies in Indian patients of atopic dermatitis V. K. Somani .................................................................................................................................................................. 100 Chronic idiopathic urticaria: Comparison of clinical features with positive autologous serum skin test George Mamatha, C. Balachandran, Prabhu Smitha ................................................................................................ 105 Autologous serum therapy in chronic urticaria: Old wine in a new bottle A. K. Bajaj, Abir Saraswat, Amitabh Upadhyay, Rajetha Damisetty, Sandipan Dhar ............................................ 109 Use of patch
    [Show full text]
  • 100 CASES in Dermatology This Page Intentionally Left Blank 100 CASES in Dermatology
    100 CASES in Dermatology This page intentionally left blank 100 CASES in Dermatology Rachael Morris-Jones PhD PCME FRCP Consultant Dermatologist & Honorary Senior Lecturer, King’s College Hospital, London, UK Ann-Marie Powell Consultant Dermatologist, Department of Dermatology, St Thomas’ Hospital, London, UK Emma Benton MB ChB MRCP Post-CCT Clinical Research Fellow, St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Trust, London, UK 100 Cases Series Editor: Professor P John Rees MD FRCP Dean of Medical Undergraduate Education, King’s College London School of Medicine at Guy’s, King’s and St Thomas’ Hospitals, London, UK First published in Great Britain in 2011 by Hodder Arnold, an imprint of Hodder Education, a division of Hachette UK 338 Euston Road, London NW1 3BH http://www.hodderarnold.com © 2011 Rachael Morris-Jones, Ann-Marie Powell and Emma Benton All rights reserved. Apart from any use permitted under UK copyright law, this publication may only be reproduced, stored or transmitted, in any form, or by any means with prior permission in writing of the publishers or in the case of reprographic production in accordance with the terms of licences issued by the Copyright Licensing Agency. In the United Kingdom such licences are issued by the Copyright Licensing Agency: Saffron House, 6–10 Kirby Street, London EC1N 8TS Hachette UK’s policy is to use papers that are natural, renewable and recyclable products and made from wood grown in sustainable forests. The logging and manufacturing processes are expected to conform to the environmental regulations of the country of origin.
    [Show full text]